Health Care: Drugs

Galena Biopharma Inc (GALE: NASDAQ)

$1.9 n/a | n/a%
10/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.90
52 Week High 7.77
52 Week Low 1.56
Avg. Daily Vol. (Mil) 1.76
Beta (3 year) 0.84
Share Related Items
Mkt Cap (Mil) 224.59
Shares Out (Mil) 118.21
Float (Mil) 117.35
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.20
Current Ratio 1.30
LT Debt/ Equity 0.21
Total Debt / Equity 0.36
Valuation Ratios
Price Earnings n.a.
Price/Sales 32.13
Price/Book 7.93
Price/Cash Flow -2.80
Per Share Data
Earnings -0.82
Sales 0.06
Book Value 0.24
Cash Flow -0.67
Business Summary
Galena Biopharma Inc, is a biopharmaceutical company focused on developing and commercializing, targeted treatments that address unmet medical needs to advance cancer care.
General Information
4640 South West Macadam Aven
Suite 270
Portland, OR 97239
www.galenabiopharma.com
Industry : Drugs
Sector: Health Care
Employees: 60
CEO: Dr. Mark W. Schwartz, Ph
Short Interest
Current Month (Mil) 21.16
Previous Month (Mil) 21.01
Short Interest Ratio (Days) 13.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -100.00
Return on Investments -233.80
Profitability
Gross Margin 90.80
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with GALE

Latest GALE Headlines from TheStreet

More Financial News for GALE

Press Releases for GALE

See All Press Releases

Partner Headlines for GALE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter